SARS‐CoV‐2 infection in children with cystic fibrosis: A cross‐sectional multicenter study in Spain. New waves, new knowledge
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26644 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Pedro Mondejar-Lopez und 35 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain. Hauptthemen laut MEDLINE: COVID-19, Cystic Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
The association between viral infections and pulmonary exacerbations in children with cystic fibrosis (cwCF) is well established. However, the question of whether cwCF are at a higher risk of COVID‐19 or its adverse consequences remains controversial.
Methods
We conducted an observational, multicenter, cross‐sectional study of cwCF infected by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) between March 2020 and June 2022, (first to sixth COVID‐19 pandemic waves) in Spain. The study aimed to describe patients' basal characteristics, SARS‐CoV‐2 clinical manifestations and outcomes, and whether there were differences across the pandemic waves.
Results
During study time, 351 SARS‐CoV2 infections were reported among 341 cwCF. Median age was 8.5 years (range 0–17) and 51% were female. Cases were unevenly distributed across the pandemic, with most cases (82%) clustered between November 2021 and June 2022 (sixth wave, also known as Omicron Wave due to the higher prevalence of this strain in that period in Spain). Most cwCF were asymptomatic (24.8%) or presented with mild Covid‐19 symptoms (72.9%). Among symptomatic, most prevalent symptoms were fever (62%) and increased cough (53%). Infection occurring along the sixth wave was the only independent risk factor for being symptomatic. Just eight cwCF needed hospital admission. No multisystem inflammatory syndrome, persisting symptoms, long‐term sequelae, or deaths were reported.
Conclusions
Spanish current data indicate that cwCF do not experience higher risks of SARS‐CoV‐2 infection nor worse health outcomes or sequelae. Changes in patients' basal characteristics, clinical courses, and outcomes were detected across waves. While the pandemic continues, a worldwide monitoring of COVID‐19 in pediatric CF patients is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain.
- Department of Surgery, Paediatrics, Obstetrics and Genecology, Biomedical Research Institute of Murcia (IMIB), Universidad de Murcia, Murcia, Spain.
- Department of Pediatrics, Complejo Hospitalario de Navarra, Servicio Navarro de Salud, Pamplona, Spain.
- IdiSNA (Instituto de Investigación Sanitaria de Navarra), Navarra Institute for Health Research, Pamplona, Spain.
- Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital La Paz Institute for Health Research-IdiPAZ, Madrid, Spain.
- Pediatric Pulmonology Department and Cystic Fibrosis Unit, Hospital Ramón y Cajal & Institute for Health Research-IRYCIS, Madrid, Spain.
ORCID-Profile: Pedro Mondejar-Lopez, Laura Moreno-Galarraga, Cristina de Manuel-Gomez, Maynor Bravo-Lopez, Alejandro Lopez-Neyra, Silvia Castillo-Corullon, Catalina Bover-Bauza, Manuel Sanchez-Solis
Zitieren
APA
Mondejar-Lopez, P., Moreno-Galarraga, L., de Manuel-Gomez, C., Blitz-Castro, E., Bravo-Lopez, M., Gartner, S., Perez-Ruiz, E., Caro-Aguilera, P., Sanz-Santiago, V., Lopez-Neyra, A., Luna-Paredes, C., Garcia-Gonzalez, M., Costa-Colomer, J., Cols-Roig, M., Delgado-Pecellin, I., Castillo-Corullon, S., Ruiz de Valbuena-Maiz, M., Garcia-Marcos, P. W., Aguilar-Fernandez, A. J., …, & Pastor-Vivero, M. D. (2023). SARS‐CoV‐2 infection in children with cystic fibrosis: A cross‐sectional multicenter study in Spain. New waves, new knowledge. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26644
Vancouver
Mondejar-Lopez P, Moreno-Galarraga L, de Manuel-Gomez C, Blitz-Castro E, Bravo-Lopez M, Gartner S, et al. SARS‐CoV‐2 infection in children with cystic fibrosis: A cross‐sectional multicenter study in Spain. New waves, new knowledge. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26644
BibTeX
@article{MondejarLopez2023,
author = {Mondejar-Lopez, Pedro and Moreno-Galarraga, Laura and de Manuel-Gomez, Cristina and Blitz-Castro, Enrique and Bravo-Lopez, Maynor and Gartner, Silvia and Perez-Ruiz, Estela and Caro-Aguilera, Pilar and Sanz-Santiago, Veronica and Lopez-Neyra, Alejandro and Luna-Paredes, Carmen and Garcia-Gonzalez, Miguel and Costa-Colomer, Jordi and Cols-Roig, Maria and Delgado-Pecellin, Isabel and Castillo-Corullon, Silvia and Ruiz de Valbuena-Maiz, Marta and Garcia-Marcos, Patricia W and Aguilar-Fernandez, Antonio J and Martin-De Vicente, Carlos and Barajas-Sanchez, Mª Verisima and Mesa-Medina, Orlando and Bover-Bauza, Catalina and Figuerola-Mulet, Joan and Garcia-Aviles, Belen and Rodriguez-Saez, Mª Jesus and Garcia-Magan, Carlos and Juarez-Marruecos, Patricia and Gutierrez-Martinez, Jose Ramon and Cortell-Aznar, Isidoro and Gomez-Pastrana, David and Velasco-Gonzalez, M Valle and Barrio, M Isabel and Sanchez-Solis, Manuel and Asensio de la Cruz, Oscar and Pastor-Vivero, Maria Dolores},
title = {SARS‐CoV‐2 infection in children with cystic fibrosis: A cross‐sectional multicenter study in Spain. New waves, new knowledge},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26644}
}
EUVIMED